Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding

FEBS Letters

Volumn 445, Issue 1, 1999, Pages 19-22

  Yamamoto, Hideko ^a   Miura, Reiko ^a   Yamamoto, Toshifumi ^a,b   Shinohara, Keiko ^a   Watanabe, Masayuki ^a   Okuyama, Shigeru ^c   Nakazato, Atsuro ^c   Nukada, Toshihide ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Medicinal Research Laboratories   (Japan)

Author keywords

Immunoblot analysis; Ligand binding; Site directed mutagenesis; Transmembrane domain; Type 1 sigma receptor; Xenopus oocyte

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; MUTANT PROTEIN; PENTAZOCINE; SIGMA OPIATE RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; DRUG RECEPTOR BINDING; IMMUNOBLOTTING; LIGAND BINDING; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; XENOPUS;

AMINO ACIDS; ANIMALS; ANISOLES; BINDING SITES; CELL MEMBRANE; GENE EXPRESSION; GUINEA PIGS; LIGANDS; OOCYTES; PENTAZOCINE; PROPYLAMINES; RABBITS; RECEPTORS, SIGMA; XENOPUS;

EID: 0033040295     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00084-8     Document Type: Article

References (27)

1. Martin W.R., Eades C.G., Thomson J.A., Hoppler R.E., Gilbert P.E. J. Pharmacol. Exp. Ther. 197:1976;517-532.
2. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Pharmacol. Rev. 42:1990;355-402.
3. Weissman A.D., Casanova M.F., Kleinman J.E., London E.D., De Souza E.B. Biol. Psychiatry. 29:1991;41-54.
4. Witkin J.M. Neurosci. Biobehav. Rev. 18:1994;121-142.
5. Liu Y., Whitlock B.B., Pultz J.A., Wolfe S.A. Jr. J. Neuroimmunol. 59:1995;143-154.
6. Hanner M., Moebius F.F., Flandorfer A., Knaus H.-G., Striessnig J., Kempner E., Glossmann H. Proc. Natl. Acad. Sci. USA. 93:1996;8072-8077.
7. Kekuda R., Prasad P.D., Fei Y.-J., Leibach F.H., Ganapathy V. Biochem. Biophys. Res. Commun. 229:1996;553-558.
8. Seth P., Leibach F.H., Ganapathy V. Biochem. Biophys. Res. Commun. 241:1997;535-540.
9. Prasad P.D., Li H.W., Fei Y.-J., Ganapathy M.E., Fujita T., Plumley L.H., Yang-Feng T.L., Leibach F.H., Ganapathy V. J. Neurochem. 70:1998;443-451.
10. Seth P., Fei Y.-J., Li H.W., Huang W., Leibach F.H., Ganapathy V. J. Neurochem. 70:1998;922-931.
11. Jbilo O., Vidal H., Paul R., De Nys N., Bensaid M., Silve S., Carayon P., Davi D., Galiègue S., Bourrié B., Guillemot J.-C., Ferrara P., Loison G., Maffrand J.-P., Le Fur G., Casellas P. J. Biol. Chem. 272:1997;27107-27115.
12. Okuyama S., Imagawa Y., Ogawa S., Araki H., Ajima A., Tanaka M., Muramatsu M., Nakazato A., Yamaguchi K., Yoshida M., Otomo S. Life Sci. 53:1993;PL285-290.
13. Nakamura K., Nukada T., Haga T., Sugiyama H. J. Physiol. 474:1994;35-41.
14. Takao K., Yoshii M., Kanda A., Kokubun S., Nukada T. Neuron. 13:1994;747-755.
15. Goodhardt M., Ferry N., Buscaglia M., Baulieu E.-E., Hanoune J. EMBO J. 3:1984;2653-2657.
16. Jones D.H., Matus A.I. Biochim. Biophys. Acta. 356:1974;276-287.
17. Towbin H., Staehelin T., Gordon J. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
18. Adams J.C. J. Histochem. Cytochem. 29:1981;775.
19. Chaki S., Tanaka M., Muramatsu M., Otomo S. Eur. J. Pharmacol. 251:1994;R1-R2.
20. Sagi N., Yamamoto H., Yamamoto T., Okuyama S., Moroji T. Eur. J. Pharmacol. 304:1996;185-190.
21. Munson P.J., Rodbard D. Anal. Biochem. 107:1980;220-239.
22. Schuster D.I., Arnold F.J., Murphy R.B. Brain Res. 670:1995;14-28.
23. DeHaven-Hudkins D.L., Fleissner L.C., Ford-Rice F.Y. Eur. J. Pharmacol. 227:1992;371-378.
24. Strader C.D., Sigal I.S., Candelore M.R., Rands E., Hill W.S., Dixon R.A.F. J. Biol. Chem. 263:1988;10267-10271.
25. Fraser C.M., Wang C.-D., Robinson D.A., Gocayne J.D., Venter J.C. Mol. Pharmacol. 36:1989;840-847.
26. Page K.M., Curtis C.A.M., Jones P.G., Hulme E.C. Eur. J. Pharmacol. 289:1995;429-437.
27. Javitch J.A., Li X., Kaback J., Karlin A. Proc. Natl. Acad. Sci. USA. 91:1994;10355-10359.